BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 19146436)

  • 21. Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands.
    Melchart M; Habtemariam A; Parsons S; Sadler PJ
    J Inorg Biochem; 2007 Nov; 101(11-12):1903-12. PubMed ID: 17582501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative DFT study on aquation and nucleobase binding of ruthenium (II) and osmium (II) arene complexes.
    Wang H; Zeng X; Zhou R; Zhao C
    J Mol Model; 2013 Nov; 19(11):4849-56. PubMed ID: 24037457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure, electronic properties and cytotoxic activity of palladium chloride complexes with monosubstituted pyridines.
    Krogul A; Cedrowski J; Wiktorska K; Ozimiński WP; Skupińska J; Litwinienko G
    Dalton Trans; 2012 Jan; 41(2):658-66. PubMed ID: 22068915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
    Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
    J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
    Vrzal R; Starha P; Dvorák Z; Trávnícek Z
    J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.
    Ramakrishnan S; Rajendiran V; Palaniandavar M; Periasamy VS; Srinag BS; Krishnamurthy H; Akbarsha MA
    Inorg Chem; 2009 Feb; 48(4):1309-22. PubMed ID: 19140687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.
    Wang F; Chen H; Parsons S; Oswald ID; Davidson JE; Sadler PJ
    Chemistry; 2003 Dec; 9(23):5810-20. PubMed ID: 14673852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships for osmium(II) arene phenylazopyridine anticancer complexes functionalised with alkoxy and glycolic substituents.
    Needham RJ; Bridgewater HE; Romero-Canelón I; Habtemariam A; Clarkson GJ; Sadler PJ
    J Inorg Biochem; 2020 Sep; 210():111154. PubMed ID: 32771772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
    Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
    Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.
    Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ
    Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes.
    Bugarcic T; Nováková O; Halámiková A; Zerzánková L; Vrána O; Kaspárková J; Habtemariam A; Parsons S; Sadler PJ; Brabec V
    J Med Chem; 2008 Sep; 51(17):5310-9. PubMed ID: 18702458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
    Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
    J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
    Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
    Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
    J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer activity of osmium metalla-rectangles.
    Barry NP; Edafe F; Dyson PJ; Therrien B
    Dalton Trans; 2010 Mar; 39(11):2816-20. PubMed ID: 20200707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
    Peri D; Meker S; Shavit M; Tshuva EY
    Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer activity of dinuclear gallium(III) carboxylate complexes.
    Kaluderović MR; Gómez-Ruiz S; Gallego B; Hey-Hawkins E; Paschke R; Kaluderović GN
    Eur J Med Chem; 2010 Feb; 45(2):519-25. PubMed ID: 19926362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.